C. A. Isnardi

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Depression Is a Major Determinant of Functional Capacity in Rheumatoid Arthritis

C. A. Isnardi, Dafne Capelusnik, Emilce E. Schneeberger et al. · JCR Journal of Clinical Rheumatology · 2020 · 35 citations

Medicine, Clinical Sciences, Internal Medicine +17

Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry

C. A. Isnardi, Karen Roberts, Verónica Saurit et al. · Clinical Rheumatology · 2022 · 21 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10

An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry—protocol and preliminary data

C. A. Isnardi, Emilce E. Schneeberger, Jennifer L. Kreimer et al. · Clinical Rheumatology · 2022 · 13 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12